Liver Stiffness Measurement by Vibration Controlled Transient Elastography Does Not Correlate to Hepatic Iron

Peter Costa1, Bryan Rudolph2, Debora Kogan-Liberman2

  • 1Section of Pediatric Gastroenterology, Brenner Children's Hospital, Wake Forest Baptist Health, Winston-Salem, NC.

Insights

Liver stiffness in children with sickle cell disease (SCD) may be elevated with age, but not directly linked to iron overload from transfusions. Vibration controlled transient elastography (VCTE) is a feasible tool for monitoring liver health in these patients.

Area of Science:

  • Pediatric Hepatology
  • Hematology
  • Medical Technology

Background:

  • Children with sickle cell disease (SCD) face risks of liver injury from sickle cell hepatopathy and iron overload due to chronic transfusions (CT).
  • Assessing liver health noninvasively is crucial for managing SCD complications.

Purpose of the Study:

  • To investigate the association between iron overload and liver stiffness measurement (LSM) in children with SCD.
  • To evaluate the utility of vibration controlled transient elastography (VCTE) in this pediatric population.

Main Methods:

  • Vibration controlled transient elastography (VCTE) was performed on pediatric patients (≤21 years) with SCD.
  • Magnetic resonance imaging T2* was used for iron quantification in patients who received CT.
  • Liver stiffness measurements (LSM) were compared between patients with and without CT and correlated with iron levels.

Main Results:

  • No significant difference in LSM was observed between patients who received CT and those who did not (P=0.923).
  • No correlation was found between iron quantification and LSM (r=-0.077, P=0.769).
  • Children aged 12 years and older demonstrated abnormal LSM compared to reference ranges (P=0.013).

Conclusions:

  • VCTE is a feasible noninvasive method for assessing liver stiffness in children with SCD.
  • Elevated LSM in older children suggests potential liver disease progression, independent of iron overload alone.
  • LSM may serve as a valuable tool for monitoring liver disease in SCD, regardless of iron burden.
Abstract